Texas AG Investigating Energy Drinks: What Pharma Teams Need to Know

Texas AG Investigating Energy Drinks: What Pharma Teams Need to Know

Texas Attorney General Ken Paxton has launched an investigation into Celsius Holdings over marketing practices and caffeine levels in its energy drinks — the sharpest state-level escalation yet in the Texas AG investigating energy drinks for potential risks to minors. This article breaks down the development, its implications for pharma and beverage companies, and key questions for industry teams.

Key Takeaways

• Texas AG Ken Paxton is investigating Celsius Holdings over caffeine levels and marketing practices, citing the need to protect children from excessive caffeine intake.
• The probe follows a wrongful death lawsuit filed by the family of a Texas teen against an Alani Nu distributor, which alleged the drinks were “dangerously” caffeinated.
• Pharma and beverage teams should monitor for regulatory ripple effects on caffeine-containing products, including dietary supplements and functional beverages marketed to younger demographics.

What triggered the Texas investigation?

Texas Attorney General Ken Paxton announced the investigation into Celsius Holdings, Inc. on June 5, 2026, under the state’s consumer protection authority. In a press release, Paxton said his office was examining Celsius’s “representations and practices” concerning its energy drinks, specifically to protect Texas children from dangerous caffeine loads. The formal probe did not emerge in a vacuum. It follows a wrongful death lawsuit filed by the family of a Texas teenager against an energy drink distributor, which claimed that Alani Nu energy drinks were “dangerously” caffeinated, as STAT reported. Public discussion on social media and elsewhere has since linked Celsius to excessive caffeine consumption among minors, amplifying pressure on state regulators to act.

For companies marketing caffeinated beverages, this sequence of events tracks a familiar pattern: a tragic incident involving a minor, followed by civil litigation, then state attorney general scrutiny. The Texas action is the first known state-level enforcement move targeting a major energy drink brand specifically on caffeine content and youth marketing, which sets it apart from earlier FDA warning letters or class-action suits focused on labeling disputes.

Why should pharma and beverage teams care?

This investigation signals a material escalation in state-level regulatory attention on caffeine levels in consumer products, particularly those that reach adolescents. Pharmaceutical and beverage companies that manufacture, distribute, or co-brand caffeine-containing items — including dietary supplements, over-the-counter stimulants, and functional beverages — face a clear read-across risk. The FDA has long issued guidance on safe caffeine limits in foods and supplements, but state attorneys general can move faster and with different enforcement tools than the federal agency. A single state probe can trigger multistate investigations, consumer class actions, and demands for label changes that ripple across the national market.

Teams should begin by auditing their product portfolios for caffeine concentration levels, especially for any SKUs marketed or implicitly positioned toward younger consumers. Marketing materials, social media campaigns, and influencer partnerships deserve particular scrutiny. The Celsius probe centers on “representations and practices” — a broad mandate that can encompass everything from advertising imagery to claims about energy or focus. Companies should also track whether the Texas attorney general refers findings to the FDA or shares evidence with other states, which would amplify the regulatory and legal pressure.

Investors and business development analysts should watch for potential class-action filings targeting beverage companies with caffeine levels above 200 mg per serving, as well as any state legislative proposals to cap caffeine in products marketed to minors. The near-term financial impact for Celsius remains uncertain, but the precedent is clear: state enforcement on caffeine is now a live risk, and the cost of defending an investigation — let alone a settlement or judgment — can run into eight figures.

Frequently Asked Questions